Europe, the Middle East, and Africa Blood Glucose Monitoring Market Research Report- Forecast till 2027

EMEA Blood Glucose Monitoring Market Information, By Product Types (Invasive Glucose Monitoring, CGM, Flash Glucose Monitoring), Applications (Type 1 Diabetes, Type 2 Diabetes), and End Users (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2027

ID: MRFR/MED/0164-HCR | February 2021 | Region: Global | 115 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


One of the main objectives of diabetes treatment is to keep blood glucose level within a specified target range. Blood glucose monitoring is a process, which helps to identify the blood glucose level and notify if glucose level of blood is exceeding the limit. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.


The blood glucose monitoring devices market is growing rapidly owing to the increasing prevalence of diabetes, innovative technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.


Various blood glucose monitoring devices are available in the Europe and the Middle East and African market, which is referred as blood glucose meter. These device help to identify the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes such as Type 1 and Type 2.


Blood Glucose monitoring devices market is expected to grow at a CAGR of 6% during the forecast period 2017-2023. Increasing diabetic patient in the Europe has increased the blood glucose monitoring devices market. Different types of glucose monitoring devices are available in the market such as blood glucose meter, continuous glucose monitoring system, Lancets, glucose monitoring strips, and others. Self-monitoring devices are the oldest method for monitoring blood glucose level and are widely used in home, hospital, and clinics.


EMEA blood glucose monitoring market is expected to reach USD 559 million by 2023 at a CAGR of approximately 6% during the forecast period 2017-2023.


Research Methodology
Europe Blood Glucose Monitoring Market-


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Blood Glucose Monitoring Devices Suppliers

  • Blood Glucose Monitoring Devices Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Segmentations


The Europe and the Middle East and Africa, blood glucose monitoring devices market is segmented on the basis of product type, application, and end user


On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.


On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.


On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.


Figure: Market Synopsis of Blood Glucose Monitoring Market by Region, 2016 (%):
Europe Blood Glucose Monitoring Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Regional Analysis


On the regional basis, Europe, Middle East, and Africa blood glucose monitoring market is segmented into two major regions Europe and the Middle East and Africa.


Europe blood glucose monitoring devices market is showing swift growth owing to the increasing diabetic and obese population, unhealthy food, lack of exercise, and many another factor. Europe is leading the market growth with 60% of market share of EMEA market. According to the WHO, in 2016, around 60 million people had diabetes, and its prevalence is increasing in all age groups in Europe.


The Middle East and Africa account for the least share of market owing to poor political conditions in Africa and limited availability of funds and availability of medical facilities but, sound growth is expected over the review period. The Middle East holds the major share of the Middle East & African market due to the presence of well-developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market.


Key Players


Some of the key players in this market are Abbott Laboratories (US), Arkay Inc. (Japan), Bayer Healthcare AG, (Germany), F.Hoffmann-La Roche (Switzerland), LifeScan, Johnson & Johnson (U.S.), Medtronic plc., Nipro Diagnostics Inc., and Terumo Medical Corporation. 



Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. EMEA Blood Glucose Monitoring Market, by Product Type

6.1 Introduction

6.2 Invasive Glucose Monitoring Devices

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Continuous Glucose Monitoring Devices

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Flash Glucose Monitoring Devices

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Others

7. EMEA Blood Glucose Monitoring Market, by Application

7.1 Introduction

7.2 Type 1 Diabetes

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Type 2 Diabetes

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020-2027

8. EMEA Blood Glucose Monitoring Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Clinics

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Research centers

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Homecare Diagnostics

8.6.1 Market Estimates & Forecast, 2020-2027

9. EMEA Blood Glucose Monitoring Market, by Region

9.1 Introduction

9.2 Europe

9.2.1 Western Europe

9.2.1 Germany

9.2.2 France

9.2.3 U.K.

9.2.4 Italy

9.2.5 Spain

9.2.6 Rest of Western Europe

9.2.2 Eastern Europe

9.3 The Middle East & Africa

9.3.1 United Arab Emirates

9.3.2 Saudi Arabia

9.3.3 Oman

9.3.4 Kuwait

9.3.5 Qatar

9.3.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Arkay, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bayer Healthcare AG

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 F. Hoffmann-La Roche

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 LifeScan

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix


LIST OF TABLES

Table 1 Blood glucose monitoring Industry Synopsis, 2020-2027

Table 2 EMEA Blood glucose monitoring Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 EMEA Blood glucose monitoring Market by Country, 2020-2027, (USD Million)

Table 4 EMEA Blood glucose monitoring Market by Product Type, 2020-2027, (USD Million)

Table 5 EMEA Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 6 EMEA Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 7 Germany Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 8 Germany Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 9 Germany Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 10 France Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 11 France Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 12 France Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 13 United Kingdom Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 14 United Kingdom Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 15 United Kingdom Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 16 Italy Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 17 Italy Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 18 Italy Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 19 Spain Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 20 Spain Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 21 Spain Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 22 Rest of Western Europe Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 23 Rest of Western Europe Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 24 Rest of Western Europe Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 25 United Arab Emirates Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 26 United Arab Emirates Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 27 United Arab Emirates Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 28 Saudi Arabia Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 29 Saudi Arabia Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 30 Saudi Arabia Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 31 Oman Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 32 Oman Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 33 Oman Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 34 Kuwait Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 35 Kuwait Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 36 Kuwait Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 37 Qatar Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 38 Qatar Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 39 Qatar Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 40 Rest of the Middle East & Africa Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 41 Rest of the Middle East & Africa Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 42 Rest of the Middle East & Africa Blood glucose monitoring Market by End User, 2020-2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for EMEA Blood Glucose Monitoring Market

Figure 3 Segmentation Market Dynamics for Blood Glucose Monitoring Market

Figure 4 EMEA Blood Glucose Monitoring Market Share, by Product Type 2020

Figure 5 EMEA Blood Glucose Monitoring Market Share, by Application 2020

Figure 6 EMEA Blood Glucose Monitoring Market Share, by End User, 2020

Figure 7 EMEA Blood Glucose Monitoring Market Share, by Country, 2020

Figure 8 EMEA Blood Glucose Monitoring Market: Company Share Analysis, 2020 (%)

Figure 9 Abbott Laboratories.: Key Financials

Figure 10 Abbott Laboratories.: Segmental Revenue

Figure 11 Abbott Laboratories.: Geographical Revenue

Figure 12 Arkay, Inc.: Key Financials

Figure 13 Arkay, Inc.: Segmental Revenue

Figure 14 Arkay, Inc.: Geographical Revenue

Figure 15 Bayer Healthcare AG: Key Financials

Figure 16 Bayer Healthcare AG: Segmental Revenue

Figure 17 Bayer Healthcare AG: Geographical Revenue

Figure 18 F. Hoffmann-La Roche: Key Financials

Figure 19 F. Hoffmann-La Roche: Segmental Revenue

Figure 20 F. Hoffmann-La Roche: Geographical Revenue

Figure 21 LifeScan Diagnostics Inc.: Key Financials

Figure 22 LifeScan Diagnostics Inc.: Segmental Revenue

Figure 23 LifeScan Diagnostics Inc.: Geographical Revenue